ALK and mature T-cell and NK-cell non-Hodgkin lymphoma: In addition to the good prognosis of anaplastic lymphoma kinase positive anaplastic large cell lymphoma (ALK + ALCL), the other PTCL subtypes have poor response to chemotherapy and are prone to relapse, and the long-term survival rate is less than 30%, which is significantly worse than B-NHL2–4.